• Blog
  • European In Vitro Diagnostics Market

    European In Vitro Diagnostics Market

    European In Vitro Diagnostics Market
    Report code - SRHL132 Published On : Nov,2018 No. of Pages: 170
    Get Free Sample |
    European In Vitro Diagnostics Market Size, Share, Trend, Forecast, Competitive Analysis, a See more...

    Market Insights

    European In Vitro Diagnostics Market is likely to witness an impressive CAGR of 5.5% during the forecast period.

    European-In-Vitro-Diagnostics-Market-Snapshot

    Want to have a closer look at this report, Download a free sample here

    What is in vitro diagnostics?

    In vitro diagnostics (IVD) tests are done on samples such as blood or tissue that have been taken from the human body. These tests are used to detect diseases and infections and to monitor the health of a person to treat and prevent diseases. In vitro simply means ‘in glass, thus these tests are performed in test tubes and similar equipment.

    Market Drivers

    Major factors driving the market growth are-

    • An increase in the number of genetic disorders, 
    • An increase in the number of incidences of chronic and infectious diseases,
    • Growing awareness for the early diagnosis of life-threatening diseases,
    • Increasing demand for point-of-care testing

    Furthermore, technological advancements in the field of in vitro diagnostic technologies are expected to drive the growth of the market during the forecast period.

    Segment Analysis

    Share Analysis: By Product Type

    Based on the product type, the market is segmented as instruments, reagents, software, and services. The reagents segment is expected to hold the major share of the market during the forecast period owing to its high precision and accuracy in diagnosis. Furthermore, the Covid-19 pandemic has increased the demand for reagents. Also, an increase in the use of self-diagnosis tests and the number of R&D activities is expected to drive market growth during the forecast period.

    Share Analysis: By Technique Type

    Based on the technique type, the market is segmented as immunology, hematology, clinical chemistry, molecular diagnostics, coagulation, microbiology, and others. The molecular diagnostics segment is anticipated to register high growth in the market owing to the increasing demand for molecular diagnosis in infectious diseases. Furthermore, the rapid rise in chronic diseases, as well as the increase in the number of genetic disorders, is expected to drive market growth during the forecast period.

    Share Analysis: By Application Type

    Based on the application type, the market is segmented as infectious diseases, diabetes, oncology/cancer, cardiology, nephrology, autoimmune diseases, drug testing, and others. The infectious diseases application type segment is estimated to account for the major share of the market during the forecast period on account of the increasing number of infectious diseases such as HIV-AIDS, hepatitis, and Respiratory Syncytial Virus. 

    Share Analysis: By Country

    In terms of country, Germany is estimated to be the leading country in the market over the forecast period. The growth of the market is owing to the increasing prevalence of infectious diseases and the growing demand for rapid tests. Furthermore, the presence of various manufacturing companies is expected to fuel market growth over the forecast period. The UK is also expected to offer substantial growth opportunities during the forecast period.

    European-In-Vitro-Diagnostics-Market-Regional-Analysis

    Want to know which region offers the best growth opportunities then,

    Market Scope & Segmentation

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

    Report Features

    Market Segmentation

    5

    Regions Covered

    4

    Countries/Sub-Regions Covered

    6

    No. of Figures & Tables

    >150

    Company Profiles

    10

     

    The market is segmented into the following categories.

    By Product Type

    • Instruments
    • Reagents
    • Software
    • Services

    By Technique Type

    • Immunology 
    • Hematology
    • Clinical Chemistry
    • Molecular Diagnostics
    • Coagulation
    • Microbiology
    • Others

    By Application Type

    • Infectious Diseases
    • Diabetes
    • Oncology/Cancer
    • Cardiology
    • Nephrology
    • Autoimmune Diseases
    • Drug Testing
    • Others

    By End-User Type

    • Hospitals
    • Laboratory
    • Home Care
    • Others

    By Country

    • Germany (Trend and Forecast)
    • France (Trend and Forecast)
    • The UK (Trend and Forecast)
    • Russia (Trend and Forecast)
    • Spain (Trend and Forecast)
    • Rest of Europe (Trend and Forecast)

    European-In-Vitro-Diagnostics-Market-Segmentation

    Know more about various segments of this report. 

    Top Players

    Some of the top players in the market are:

    • Abbott Laboratories, Inc.,
    • Alere, Inc.,
    • Bio-Rad Laboratories, Inc.,
    • Cepheid, Inc.,
    • Hologic, Inc.,
    • OraSure Technologies,
    • Qiagen N.V.,
    • Quidel Corporation,
    • Roche Diagnostics,
    • Siemens Healthcare GmbH.

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

    • Market structure: Overview, industry life cycle analysis, supply chain analysis
    • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
    • Market trend and forecast analysis
    • Market segment trend and forecast
    • Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
    • Attractive market segments and associated growth opportunities
    • Emerging trends
    • Strategic growth opportunities for the existing and new players
    • Key success factors

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Market Segmentation

    • Current market segmentation by any one of the technique types by application type.  

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com

    Frequently Asked Questions

    The growth rate of the market will be 5.5% CAGR during the forecast period.

    Abbott Laboratories, Inc., Alere, Inc., Bio-Rad Laboratories, Inc., Cepheid, Inc., Hologic, Inc., OraSure Technologies, Qiagen N.V., Quidel Corporation, Roche Diagnostics, and Siemens Healthcare GmbH.

    Germany is estimated to be the leading country in the market.

    The reagents segment holds the major share of the market.

    The molecular diagnostics segment is anticipated to register high growth in the market.

    In vitro diagnostics (IVD) tests are done on samples such as blood or tissue that have been taken from the human body. These tests are used to detect diseases and infections and to monitor the health of a person to treat and prevent diseases. In vitro simply means in glass, thus these tests are performed in test tubes and similar equipment.

    Major factors driving the market growth are an increase in the number of genetic disorders, an increase in the number of incidences of chronic and infectious diseases, growing awareness for the early diagnosis of life-threatening diseases, and Increasing demand for point-of-care testing. Furthermore, technological advancements in the field of in vitro diagnostic technologies are expected to drive the growth of the market during the forecast period.

    •   
    ×